one hundred and twenty nine de novo patients with idiopathic parkinson 's disease are being followed over a 5 year period in a double-blind multicentre study comparing low-dose bromocriptine ( less than 30 mg/day ) with low-dose levodopa-carbidopa ( less than 600/150 mg/day ) .
C0030567
idiopathic parkinson 's disease
C0006230
bromocriptine